Suchergebnisse - "Banerji, Versha"

PubPharm (81)

1

Venetoclax in patients with relapsed or refractory chronic lymphocytic leukaemia

enthalten in: The Lancet. Oncology | 2024

von Yang, L. | Banerji, V.

2

Management and use of healthcare resources in patients with chronic lymphocytic leukemia initiating venetoclax in routine clinical practice

enthalten in: Leukemia & lymphoma | 2024

von Banerji, V. | Aw, A. | Laferriere, N. | +11

3

PI3K-dependant reprogramming of hexokinase isoforms controls glucose metabolism and functional responses of B lymphocytes

enthalten in: bioRxiv.org | 2024

von Paradoski, B. | Hou, S. | Mejia, E. | +8

4

Canadian evidence-based guideline for treatment of relapsed/refractory chronic lymphocytic leukemia

enthalten in: Leukemia research | 2023

von Owen, C. | Eisinga, S. | Banerji, V. | +5

5

Mapping gender and sexual minority representation in cancer research : a scoping review protocol

enthalten in: CMAJ open | 2023

von Stirling, M. | Hunter, M. | Ludwig, C. | +8

6

Elevated expression of interleukin 16 in chronic lymphocytic leukemia is associated with disease burden and abnormal immune microenvironment

enthalten in: Leukemia research | 2023

von Wu, X. | Thisdelle, J. | Hou, S. | +6

7

Clinical Outcomes in a Large Canadian Centralized CLL Clinic Based on Treatment and Molecular Factors over a Decade

enthalten in: Current oncology (Toronto, Ont.) | 2023

von Yang, J. | Yang, L. | Tordon, B. | +16

8

Impact of sex on outcomes in patients with hairy cell leukemia. An HCL patient data registry analysis

enthalten in: American journal of hematology | 2023

von Epperla, N. | Zhao, Q. | Anghelina, M. | +10

9

Corrigendum to "Canadian evidence-based guideline for frontline treatment of chronic lymphocytic leukemia : 2022 update" [Leukemia Research 125 (2023) 107016

enthalten in: Leukemia research | 2023

von Owen, C. | Banerji, V. | Johnson, N. | +4

ErratumFor: Leuk Res. 2023 Feb;125:107016. - PMID 36634577

10

Metabolism-based targeting of MYC via MPC-SOD2 axis-mediated oxidation promotes cellular differentiation in group 3 medulloblastoma

enthalten in: Nature communications | 2023

von Martell, E. | Kuzmychova, H. | Kaul, E. | +11

1
2
3
4
5
6
7
8
9
Nächster »
[9]